ACT 2023 is organized by the American College of Toxicology, and the event in Orlando is the Annual Meeting. At the event, toxicologists from across the Globe will get together to network, share the latest knowledge, and get updated on everything new in the world of toxicology. As one of Scandinavia’s leading preclinical CROs with long standing expertise within this area, Scantox will of course be present at the event. With over 40 years of experience Scantox has a long track record of successfully conducting toxicology studies. The studies are performed in several species, including rodents and non-rodents.
You can meet the Scantox team at ACT 2023 on Booth 123.
 | Jeanet Løgsted CEO, Scantox Group |
 | Andy Brown CCO, Scantox group |
 | Mikkel Lykke Jensen CSO, Scantox Group |
